Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 477,776 shares at $18.22 ($8.7M) on 2024-10-01, disclosed to the SEC on 2024-10-03.
Scheduled sale ($8.7M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.18 | 94,444 | $1.7M | 19.7% |
| 2 | $18.18 | 94,444 | $1.7M | 19.7% |
| 3 | $18.22 | 144,444 | $2.6M | 30.3% |
| 4 | $18.22 | 144,444 | $2.6M | 30.3% |
| Total | $18.20 avg | 477,776 | $8.7M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |